Literature DB >> 19406125

Preconditioning with diazoxide prevents reoxygenation-induced rigor-type hypercontracture.

Y Abdallah1, C Wolf, K Meuter, H M Piper, H P Reusch, Y Ladilov.   

Abstract

Ischemic preconditioning has a powerful protective potential against a reperfusion-induced injury of the post-ischemic myocardium. Cardiomyocyte hypercontracture, i.e. excessive cell shortening, is an essential mechanism of the reperfusion-induced injury. Rigor contracture, i.e. Ca(2+)-independent contracture, has been shown to be an import component of the reperfusion-induced hypercontracture. Since rigor contracture is dependent on the rapidity of the metabolic recovery during reoxygenation, we hypothesized that preconditioning of the cardiomyocyte mitochondria may improve mitochondrial function to restore the energy balance during the initial phase of reoxygenation and may thus prevent rigor contracture. For this purpose adult rat cardiomyocytes were exposed to anoxia with subsequent reoxygenation. For preconditioning, cells were pre-treated with the mitochondrial ATP-sensitive K(+) channel opener diazoxide. Pre-treatment with 100 micromol/l diazoxide significantly reduced the reoxygenation-induced hypercontracture of cardiomyocytes due to an attenuation of the Ca(2+)-independent rigor-type contracture, which was accompanied by an acceleration of the phosphocreatine resynthesis during the initial phase of reoxygenation. Treatment with the mitochondrial ATP-sensitive K(+) channel antagonist 5-hydroxydecanoate (500 micromol/l) during preconditioning phase abolished these protective effects. Similarly, partial suppression of the mitochondrial function with 100 micromol/l NaCN during the reoxygenation phase abolished the diazoxide effects. Finally, in isolated rat hearts, preconditioning with diazoxide prior to global ischemia significantly improved left ventricular function and attenuated hypercontracture during reperfusion. This effect could be abolished by the treatment with 100 micromol/l NaCN during reperfusion. Taken together, pharmacological preconditioning of cardiomyocytes with diazoxide protects against the reoxygenation-induced rigor hypercontracture due to an improvement of the energy recovery at the onset of reoxygenation. Copyright 2009 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19406125     DOI: 10.1016/j.yjmcc.2009.04.013

Source DB:  PubMed          Journal:  J Mol Cell Cardiol        ISSN: 0022-2828            Impact factor:   5.000


  4 in total

1.  Skeletal muscle post-conditioning by diazoxide, anti-oxidative and anti-apoptotic mechanisms.

Authors:  Mehdi Moghtadaei; Rouhollah Habibey; Marjan Ajami; Mansoureh Soleimani; Soltan Ahmed Ebrahimi; Hamidreza Pazoki-Toroudi
Journal:  Mol Biol Rep       Date:  2012-10-09       Impact factor: 2.316

Review 2.  Use of nicorandil in cardiovascular disease and its optimization.

Authors:  Shigeo Horinaka
Journal:  Drugs       Date:  2011-06-18       Impact factor: 9.546

3.  Role of mitochondrial permeability transition pore and mitochondrial ATP-sensitive potassium channels in the protective effects of ischemic preconditioning in isolated hearts from fed and fasted rats.

Authors:  M G Marina Prendes; R Hermann; M E Torresin; D Vélez; E A Savino; A Varela
Journal:  J Physiol Biochem       Date:  2014-07-19       Impact factor: 4.158

4.  Remote ischemic preconditioning of cardiomyocytes inhibits the mitochondrial permeability transition pore independently of reduced calcium-loading or sarcKATP channel activation.

Authors:  Helen E Turrell; Chokanan Thaitirarot; Hayley Crumbie; Glenn Rodrigo
Journal:  Physiol Rep       Date:  2014-11-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.